8.3 C
New York
Thursday, March 28, 2024

US Stock Futures Down; Crude Oil Rises

Courtesy of Benzinga.

US Stock Futures Down; Crude Oil Rises

Related GILD
CNBC's Stock Pops & Drops From December 26
Morning Market Movers
Making Money With Charles Payne: 12/22/14 (Fox Business)

Related ATHX
Athersys Finishes Enrollment of Phase 2 Study of MultiStem(R) Cell Therapy for Ischemic Stroke
Events for the Week of Oct. 13-17, 2014

Pre-open movers

US stock futures traded lower in early pre-market trade. Crude oil futures gained 1.19% to trade at $55.38 a barrel. Futures for the Dow Jones Industrial Average dropped 37 points to 17,975.00, while the Standard & Poor’s 500 index futures fell 4.30 points to 2,079.90. Futures for the Nasdaq 100 index slipped 5.25 points to 4,305.00.

A Peek Into Global Markets

European markets were mostly lower today, with the Spanish Ibex Index falling 1.41%, STOXX Europe 600 Index dropping 0.29%. German DAX 30 index slipped 0.56%, French CAC 40 Index slipped 0.10% and London’s FTSE 100 Index rose 0.25%.

In Asian markets, Japan’s Nikkei Stock Average declined 0.50%, Hong Kong’s Hang Seng Index gained 1.82%, China’s Shanghai Composite Index rose 0.33% and India’s Sensex jumped 0.57%.

Broker Recommendation
Analysts at Morgan Stanley upgraded Gilead Sciences Inc. (NASDAQ: GILD) from undefined to Overweight.

Gilead Sciences’ shares rose 1.92% to $95.59 in pre-market trading.

Breaking news

  • Athersys, Inc. (NASDAQ: ATHX) today announced that it has concluded patient enrollment of its Phase 2 clinical study involving administration of Athersys’ MultiStem^® cell therapy to ischemic stroke patients. To read the full news, click here.
  • Così, Inc. (NASDAQ: COSI) today announced the appointment of David Lloyd to the Company’s Board of Directors, effective January 1, 2015. To read the full news, click here.
  • 500.com Limited (NYSE: WBAI) today announced that Mr. Jeffrey R. Williams has been appointed as a new independent director, effective November 22, 2014. To read the full news, click here.
  • MagnaChip Semiconductor Corporation (NYSE: MX) today announced it has launched a research collaboration focused on developing innovative, cost-effective silicon magnetic bio-sensor technology capable of monitoring extremely rare cells in blood. To read the full news, click here.

Posted-In: Morgan Stanley US Stock FuturesNews Eurozone Futures Global Pre-Market Outlook Markets

Subscribe
Notify of
0 Comments
Inline Feedbacks
View all comments

Stay Connected

157,452FansLike
396,312FollowersFollow
2,280SubscribersSubscribe

Latest Articles

0
Would love your thoughts, please comment.x
()
x